12-Month Outcomes for HM II LVAD Bridge to Transplant
Reproduced from Starling RC et al. Results of the Post-U.S. Food and Drug Administration-Approval Study With a Continuous Flow Left Ventricular Assist Device as a Bridge to Heart Transplantation. J Am Coll Cardiol 2011;57(19):1890–1898. With permission from Elsevier.